Rapid Access to Potent Bispecific T Cell Engagers Using Biogenic Tyrosine Click Chemistry
Bioconjugate Chemistry · 2023
DOI: 10.1021/acs.bioconjchem.3c00357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2023. Verfasst von Irene Shajan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Organic Chemistry, Wageningen University & Research, Stippeneng 4, Wageningen 6807 WE, The Netherlands. Hauptthemen laut MEDLINE: Neoplasms, Antibodies, Bispecific. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Universit? de Strasbourg, H2020 Marie Sklodowska-Curie Actions.
Abstract (Originalsprache)
Bispecific antibodies as T cell engagers designed to display binding capabilities to both tumor-associated antigens and antigens on T cells are considered promising agents in the fight against cancer. Even though chemical strategies to develop such constructs have emerged, a method that readily converts a therapeutically applied antibody into a bispecific construct by a fully non-genetic process is not yet available. Herein, we report the application of a biogenic, tyrosine-based click reaction utilizing chemoenzymatic modifications of native IgG1 antibodies to generate a synthetic bispecific antibody construct that exhibits tumor-killing capability at picomolar concentrations. Control experiments revealed that a covalent linkage of the different components is required for the observed biological activities. In view of the highly potent nature of the constructs and the modular approach that relies on convenient synthetic methods utilizing therapeutically approved biomolecules, our method expedites the production of potent bispecific antibody constructs with tunable cell killing efficacy with significant impact on therapeutic properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Organic Chemistry, Wageningen University & Research, Stippeneng 4, Wageningen 6807 WE, The Netherlands.
- Department of Chemistry, University College London, 20 Gordon St, London WC1H 0AJ, U.K.
- Patrick G Johnston Centre for Cancer Research, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, U.K.
- Laboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, Strasbourg 67000, France.
- Infrastructure Nationale de Protéomique ProFI - FR2048, Strasbourg 67087, France.
- Synaffix BV - A Lonza Company, Kloosterstraat 9, Oss 5349 AB, The Netherlands.
ORCID-Profile: Léa N C Rochet, Sarah Cianférani, Floris L van Delft, Vijay Chudasama, Bauke Albada
Förderung
- Agence Nationale de la Recherche
- Universit? de Strasbourg
- H2020 Marie Sklodowska-Curie Actions
- Centre National de la Recherche Scientifique
Zitieren
APA
Shajan, I., Rochet, L. N. C., Tracey, S. R., Jackowska, B., Benazza, R., Hernandez-Alba, O., Cianférani, S., Scott, C. J., van Delft, F. L., Chudasama, V., & Albada, B. (2023). Rapid Access to Potent Bispecific T Cell Engagers Using Biogenic Tyrosine Click Chemistry. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.3c00357
Vancouver
Shajan I, Rochet LNC, Tracey SR, Jackowska B, Benazza R, Hernandez-Alba O, et al. Rapid Access to Potent Bispecific T Cell Engagers Using Biogenic Tyrosine Click Chemistry. Bioconjugate Chemistry. 2023. doi:10.1021/acs.bioconjchem.3c00357
BibTeX
@article{Shajan2023,
author = {Shajan, Irene and Rochet, Léa N C and Tracey, Shannon R and Jackowska, Bianka and Benazza, Rania and Hernandez-Alba, Oscar and Cianférani, Sarah and Scott, Christopher J and van Delft, Floris L and Chudasama, Vijay and Albada, Bauke},
title = {Rapid Access to Potent Bispecific T Cell Engagers Using Biogenic Tyrosine Click Chemistry},
journal = {Bioconjugate Chemistry},
year = {2023},
doi = {10.1021/acs.bioconjchem.3c00357}
}
EUVIMED